1. Home
  2. AEHR vs CMPX Comparison

AEHR vs CMPX Comparison

Compare AEHR & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aehr Test Systems

AEHR

Aehr Test Systems

HOLD

Current Price

$89.83

Market Cap

858.8M

Sector

Industrials

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$1.72

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEHR
CMPX
Founded
1977
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.8M
927.5M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
AEHR
CMPX
Price
$89.83
$1.72
Analyst Decision
Hold
Strong Buy
Analyst Count
3
9
Target Price
$29.50
$14.57
AVG Volume (30 Days)
4.3M
10.0M
Earning Date
04-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$58,968,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$71.04
$934.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.02
$1.61
52 Week High
$102.48
$6.88

Technical Indicators

Market Signals
Indicator
AEHR
CMPX
Relative Strength Index (RSI) 68.14 20.43
Support Level $21.95 N/A
Resistance Level N/A $3.74
Average True Range (ATR) 8.35 0.50
MACD -0.70 -0.46
Stochastic Oscillator 63.80 1.72

Price Performance

Historical Comparison
AEHR
CMPX

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: